Two epitopes have been identified recently to be responsible for the high-affinity binding of alkane-bisammonium and caracurine V type allosteric ligands to N-methylscopolamine (NMS)-occupied M 2 muscarinic acetylcholine receptors, relative to M 5 receptors: the amino acid M 2 -Thr 423 at the top of transmembrane region (TM) 7 and an epitope comprising the second extracellular loop (o2) of the M 2 receptor including the flanking regions of TM4 and TM5. We aimed to find out whether a single amino acid could account for the contribution of this epitope to binding affinity. Allosteric interactions were investigated in wildtype and mutant receptors in which the orthosteric binding site was occupied by [ 3 H]NMS (5 mM Na,K,P i buffer, pH 7.4, 23°C were replaced by the corresponding amino acids of M 5 revealed that these two amino acids account entirely for the (approximately 100-fold) M 2 /M 5 selectivity of the alkane-bisammonium and the caracurine V type allosteric ligands. At NMSfree M 2 receptors, the caracurine V derivative also displayed approximately 100-fold M 2 /M 5 selectivity, but the double point mutation reduced the M 2 affinity by only ϳ10-fold; thus, additional epitopes may influence selectivity for the free receptors.
were replaced by the corresponding amino acids of M 5 revealed that these two amino acids account entirely for the (approximately 100-fold) M 2 /M 5 selectivity of the alkane-bisammonium and the caracurine V type allosteric ligands. At NMSfree M 2 receptors, the caracurine V derivative also displayed approximately 100-fold M 2 /M 5 selectivity, but the double point mutation reduced the M 2 affinity by only ϳ10-fold; thus, additional epitopes may influence selectivity for the free receptors. A three-dimensional model of the M 2 receptor was used to simulate allosteric agent docking to NMS-occupied receptors. M 2 -Tyr 177 and M 2 -Thr 423 seem to be located near the junction of the allosteric and the orthosteric areas of the M 2 receptor ligand binding cavity.
Muscarinic acetylcholine receptors are members of the rhodopsin-like family of G protein-coupled receptors, which share general structural motifs, including seven hydrophobic transmembrane helices connected by intracellular and extracellular loops, an extracellular amino terminus, and a cytoplasmic carboxyl terminus. Molecular cloning studies revealed the existence of five (M 1 -M 5 ) muscarinic acetylcholine receptors (Bonner et al., 1987) , all of which are susceptible to allosteric modulation (Ellis et al., 1991) . The orthosteric acetylcholine binding site seems to be lined by the transmembrane helices (Wess, 1993) and seems to be highly conserved among the five subtypes (Hulme et al., 1990) . The allosteric binding site is located at the entrance of the ligand binding pocket (Ellis et al., 1993; Leppik et al., 1994) and is likely to be less well conserved than the orthosteric ligand binding site, thus potentially allowing the design of ligands with greater subtype selectivity (Tuček and Proška, 1995) . The family of the muscarinic acetylcholine receptors has been widely studied as a model system for the interaction of allosteric modulators with G protein-coupled receptors (Christopoulos and Kenakin, 2002) .
It is striking that muscarinic allosteric ligands exhibit generally the highest affinity to the M 2 receptor subtype (Lee and El-Fakahany, 1991; Ellis et al., 1991; Ellis and Seidenberg, 2000) . A number of studies aimed to identify receptor epitopes that are critical for the binding of allosteric agents to the M 2 receptor (Leppik et al., 1994; Gnagey et al., 1999; Buller et al., 2002) . The use of M 2 /M 5 chimeric receptors has turned out to be an effective approach to gain more insight into receptor areas that confer the high affinity of allosteric ligands to the M 2 receptor subtype (Ellis et al., 1993; Gnagey et al., 1999; Ellis and Seidenberg, 2000) . In these experiments, we have focused on the formation of ternary complexes that are the characteristic feature of allosteric interactions. For this purpose, the interaction of the allosteric agents was measured with receptors in which the orthosteric site was occupied by [ 3 H ]N-methylscopolamine ([
H]NMS). Receptor binding of the allosteric agents is reflected by an inhibition of [
3 H]NMS dissociation. Using this procedure, we were able to identify two epitopes (Buller et al., 2002) that account fully for the high affinity of alkane-bisammoniumtype and caracurine V-type allosteric ligands (Fig. 1) to the M 2 receptor, relative to the M 5 receptor. One of these epitopes consists of a single amino acid at the beginning of the seventh transmembrane region of the M 2 receptor, M 2 -Thr 423 . The other epitope has not been so precisely located but lies either within the second outer loop of the M 2 receptor or in adjacent regions of TM4 and TM5.
In the present study, chimeric and point mutated receptors were used to examine whether the second epitope likewise consists of a single amino acid that is pivotal for the binding of these allosteric agents. We identified M 2 -Tyr 177 , in the middle region of the second outer loop of the M 2 receptor, as the critical amino acid. A double point-mutated receptor revealed that these two amino acids, M 2 -Tyr 177 and M 2 -Thr 423 , are sufficient to completely account for the M 2 /M 5 selectivity of the applied allosteric agents in the NMS-occupied receptors. To check whether these amino acids play a role for the interaction with NMS-free receptors, we carried out equilibrium binding experiments with [
3 H]NMS that were analyzed according to the ternary complex model of allosteric interactions (Stockton et al., 1983; Ehlert, 1988) . The findings suggest that the two amino acids are involved in the binding affinity of the allosteric modulators for the free M 2 receptor, but additional epitopes seem to contribute to the M 2 /M 5 - at ASPET Journals on June 25, 2017 molpharm.aspetjournals.org selectivity under this condition. A three-dimensional model of the M 2 receptor in the NMS-occupied state was built on the basis of the crystal structure of bovine rhodopsin. The model seems to be suitable to gain insight into the putative topography and the molecular mechanisms of allosteric-orthosteric interactions.
Materials and Methods

Receptor Mutagenesis and Expression
Site-directed mutagenesis was performed with the QuikChange kit (Stratagene, La Jolla, CA). In short, oligonucleotides containing the desired base changes were synthesized and allowed to anneal with pCD plasmids containing the appropriate muscarinic receptor DNA sequence. A high-fidelity polymerase then extended the synthetic oligonucleotides in a thermocycled reaction. The parental DNA was digested by a methylation-specific endonuclease, leaving only the mutated product, which was confirmed by sequencing. Subsequently, the mutated products were transformed in Escherichia coli cells and amplified overnight. Plasmids containing the human M 2 or M 5 wild-type or mutated receptor genes were purified from bacterial cultures and transiently transfected into COS-7 cells by calcium phosphate precipitation. Cells were harvested 72 h after transfection by scraping into 5 mM Na,K,P i buffer (PB), pH 7.4. After homogenization and centrifugation at 50,000g for 20 min, membranes were resuspended in 5 mM PB and stored as aliquots at Ϫ80°C. Schematic diagrams of the chimeric receptors are shown in Fig. 2 . The exact sequences of the chimeras are as follows: 
Binding Assays
Dissociation Binding Assays. Dissociation binding assays were conducted in 5 mM PB, pH 7.4, at 23°C. Membranes were preincubated with 1 nM [ 3 H]NMS for 30 min. Net dissociation of [ 3 H]NMS was initiated by the addition of 3 M atropine, with or without the indicated concentrations of allosteric modulator. After the appropriate time interval, the dissociation was terminated by filtration through Whatman GF/B glass fiber filters that had been soaked in 0.1% polyethylenimine, using a Brandel cell harvester; the filtration was immediately followed by two rinses with 40 mM PB (0°C). The filter-bound radioactivity was quantitated by liquid scintillation counting. Nonspecific binding was defined as the radioactivity bound in the presence of 3 M atropine.
Equilibrium Binding Assays. Lazareno and Birdsall (1995; eq. 31 therein) . Five observed half-life times of association were taken to be sufficient to attain equilibrium binding. Incubation times amounted for M 2 and the indicated double point mutant to 3 to 5 h and for M 5 to 24 h. Filtration and further processing was carried out as described above.
Data Analysis
Dissociation data were analyzed using the monoexponential decay equation, and apparent rate constants were obtained. Ellis, 1997; Trä nkle et al., 1998) . The concentration for a half-maximum effect on [ 3 H]NMS dissociation (EC 0.5,diss ) can be taken as a measure of affinity of the allosteric modulator for the NMS-occupied receptor.
Equilibrium binding data were analyzed according to the ternary complex model of allosteric interactions (Ehlert, 1988) using the equation Raasch et al., 2002) . EC 0.5,diss was known from the dissociation experiments and the curve fit yielded ␣. K A was then calculated as EC 0.5,diss /␣. Nonlinear regression analysis was performed using the Prism program (ver. 3.02; GraphPad Software, San Diego, CA).
Chemicals
Atropine sulfate and polyethylenimine were obtained from Sigma Chemical (Mü nchen, Germany). Diallylcaracurine V and dimethyl-W84 (Trä nkle et 
Three-Dimensional Modeling and Docking Simulations
Homology Modeling. The model is based on the X-ray structure of bovine rhodopsin (Protein Data Base accession no. 1F88/1HZX; Palczewski et al., 2000) ; the sequence of the human M 2 receptor was TABLE 1 Half-times of dissociation of ͓ 3 H͔NMS from the indicated wild-type and mutant receptors in the absence of an allosteric agent Data are presented as mean Ϯ S.E. derived from three to four independent experiments.
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at ASPET Journals on June 25, 2017 molpharm.aspetjournals.org extracted from SwissProt (code no. P08172; Bonner et al., 1987) . Transmembrane regions of the M 2 receptor were detected using so-called pinpoints, identified by Baldwin et al. (1997) . The extracellular and intracellular loops were created employing a combination of different methods [i.e., secondary structure prediction and the application of a loop search routine based on homology aspects, implemented in the Homology module of Insight II (Accelrys, San Diego, CA)]. 3D-coordinates for N and C termini were built in analogy to the X-ray structure of bovine rhodopsin. A detailed description of the modeling procedure has been given elsewhere (Jöhren and Höltje, 2003) .
Receptor-Ligand Complexes. The geometries of interaction for the allosteric modulators diallylcaracurine V and W84 were found in a stepwise manner. In a first step, the free volume located between the extracellular loops and the upper part of the transmembrane helices was explored using the program SURFNET (Laskowski, 1995) . In the next step, the large cavity, which was found, was investigated using different GRID-probes, imitating the functional groups present in the ligands. Subsequently, the allosteric modulators were manually docked into this cavity according to the favorable positions detected by GRID (Stoll et al., 2002) . The two resulting wild-type complexes (diallylcaracurine V ϩ NMS, W84 ϩ NMS) were virtually mutated (M 2 -Tyr 177 3Gln, M 2 -Thr 423 3His, M 2 -Tyr 177 3Gln ϩ Thr 423 3His), and all newly generated complexes were minimized to obtain energetically acceptable geometries.
Molecular Dynamics Simulation. To check whether the protocol for the molecular dynamics simulation was suitable, identical simulations for the X-ray structure of bovine rhodopsin as well as for the M 2 receptor model were performed. The result was confirmed that a backbone tether of 200 kcal/Å 2 , a distance dependent dielectric constant of 2 ϫ r and the use of the physiological pH of 7.4 give acceptable results when using the consistent valence force field (Accelrys). A simulation time of 300 ps is adequate for equilibration and simulation of receptor-ligand-complexes.
Model Quality Check. All molecular dynamics simulation runs were checked for equilibration of the system and protein stability. The potential energy and the root-mean-square deviation were taken as measures for complex equilibration. During the molecular dynamics simulation, the protein geometry, which was monitored with PROCHECK (Laskowski et al., 1993) , was stable. The program NMRCLUST (Kelley et al., 1996) was applied to achieve representative structures of the protein-ligand complex after equilibration. The interaction energies between the allosteric ligands and the M 2 receptor during molecular dynamics simulation were determined using the DeCipher module in Insight II (Accelrys).
Results
In a first step, we aimed to narrow down the epitope in o2 by dividing the amino acid strand into three parts: A, B, and C. Thus, M 2 /M 5 chimeric receptors were created, in which part A, B, or C of the M 2 receptor was substituted with the corresponding sequences of the M 5 receptor and vice versa. Schematic representations of the chimeric receptors are shown in Fig. 2 The dependence of the allosteric action of W84 on parts A to C of o2 is shown in Fig. 2 . Only the replacement of part B of the M 2 receptor with the corresponding sequence of the M 5 receptor resulted in a significant loss of affinity of W84 ( Fig.  2A) . The converse mutation (Fig. 2B ) (i.e., replacement of the corresponding part B of the M 5 receptor with part B of the M 2 receptor) led to a reciprocal effect; the affinity toward W84 is increased, relative to the M 5 wild-type receptor. In contrast, substitutions of part A or C had no effect on the affinity toward W84. The same pattern of effects was observed with the other allosteric modulators, dimethyl-W84 and diallylcaracurine V (Table 2 ). These results suggest that the crucial amino acid is located in part B. The sequences of part B in the M 2 and in the M 5 receptor are given in Fig. 3 .
Subsequently, site-directed mutagenesis was applied to gain more insight into the contribution of the amino acids for the binding affinity of the allosteric agents. We focused on three amino acids of part B of the M 2 receptor: (Fig. 4) , relative to the M 2 wild-type receptor. In contrast, replacement of M 2 -Tyr 177 by glutamine of M 5 markedly reduced the affinity of W84 (Fig.  4) relative to the M 2 wild-type receptor. The loss of affinity to this mutant receptor is equivalent to the loss of affinity observed when substituting the whole part B of the M 2 receptor by the corresponding part of M 5 . Similar findings were obtained for dimethyl-W84 and diallylcaracurine V ( Table 2 ). The converse mutation was also constructed, M 5 -Gln 184 3 Tyr, and the result was an increase of affinity toward all of the allosteric modulators that were studied, relative to the M 5 wild-type receptor ( Table 2 ). The loss of binding affinity that was caused by removing Tyr 177 from the M 2 receptor and the gain of binding affinity caused by introducing tyrosine into the corresponding position of M 5 suggested that M 2 -Tyr 177 is the essential amino acid within the o2 epitope of the M 2 receptor.
In a preceding study, we found that M 2 -Thr 423 is a critical epitope for the M 2 /M 5 selectivity of all the allosteric test compounds examined here. Therefore, we further investigated whether M 2 -Thr 423 and M 2 -Tyr 177 might fully account for the M 2 /M 5 selectivity of these allosteric compounds. A 
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at ASPET Journals on June 25, 2017 molpharm.aspetjournals.org double point-mutated receptor was generated, replacing the tyrosine and threonine of the M 2 receptor with the corresponding amino acids of the M 5 receptor, glutamine and histidine (M 2 -Tyr 177 3 Gln ϩ Thr 423 3 His). As shown in Fig.  4 , the affinity of W84 toward this mutant receptor matched the affinity of W84 for the wild-type M 5 receptor. The double mutation in M 2 likewise reduced the affinities toward dimethyl-W84 and diallylcaracurine V to M 5 levels ( Fig. 5 and Table 2 ). The reverse mutation, insertion of tyrosine and threonine in the M 5 receptor, resulted in a significant increase of affinity toward the allosteric agents, although the affinity level of M 2 was not obtained with any of the ligands (Table 2 ). This outcome is not altogether surprising. When an essential residue is removed from a receptor, its contribution is likely to be completely lost if the substituted residue is incapable of mimicking the lost interaction. On the other hand, the effectiveness of the insertion of such a residue may depend upon other aspects of the recipient receptor's structure (Ellis et al., 1993) . In the present case, the proline at M 5 179 might contribute to a less-than-optimal orientation of the inserted tyrosine at position 184, for example. Or there could be important structural features even further removed, as suggested by previous studies in which the entire second outer loop of M 2 , along with TM4 and TM5 residues, was inserted into M 5 ; when the threonine was additionally inserted into TM7 of this chimera, affinities were observed for several allosteric ligands that were essentially like those for M2 (Buller et al., 2002) .
The aforementioned experiments have all been conducted with NMS-occupied receptors. We aimed to check the role of (Wedig et al., 2002) in contrast to the alkane-bisammonium compounds, which are prone to undergo spontaneous degradation over the long incubation periods (24 h in this study) that are required to reach binding equilibrium in the presence of allosteric agents in M 5 receptors (t 1/2 of W84 degradation in PB is 10 -14 h; Schulz, 1998) . As shown in Fig. 6 Table 3 . In the double mutant receptor, the cooperativity with NMS was at least as negative as in M 5 , whereas the affinity of diallylcaracurine V binding remained halfway between M 2 and M 5 . Additional epitopes seem to be involved in the M 2 /M 5 selectivity of the binding of this allosteric agent to unoccupied receptors. In cases of W84 and dimethyl-W84, the double point mutation of the M 2 receptor led to losses in binding affinity of Ͼ10-fold relative to the wild-type M 2 receptor; the cooperativity with NMS was negative. Taken together, the findings indicate that the pair of amino acids plays a major role for the binding of the alkane-bisammonium-type and the caracurine V-type allosteric agents in free M 2 receptors. Future studies will have to elucidate the relative contribution of the single amino acids to the loss of binding affinity seen with all agents and to the shift in cooperativity seen with the caracurine V type agent. Furthermore, it will be interesting to find out in how far the reverse mutation M 5 -Gln 184 3 Tyr ϩ His 478 3 Thr induces a gain of binding affinity for the free receptor and restores cooperativity.
To gain more insight into the topography of allosteric agent binding to the M 2 receptor, a 3-dimensional model of the receptor protein was built (Jöhren and Höltje, 2003) . The model was derived from the crystal structure of bovine rhodopsin in the inactive state. Thus, the transmembrane helices should be in the same position as if stabilized through an orthosteric antagonist. For the modeling, NMS as the orthosteric agent offers favorable features: 1) it is relatively large and rigid and 2) the amino acids, which are important for its : carbon, green; nitrogen, dark blue; oxygen, red; hydrogen, white. Diallylcaracurine V: carbon, white; nitrogen, dark blue; oxygen, red; hydrogen, not shown.
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at ASPET Journals on June 25, 2017 molpharm.aspetjournals.org binding, are well known but different from the amino acids important for agonist binding (Heitz et al.,1999; Lu et al., 2002) . The model of the ligand binding cavity of the M 2 receptor is shown in Fig. 7 . The extracellular loops form a cleft-like vestibule that is connected through a narrow corridor with a chamber in which the orthosteric binding site is located, lined by the transmembrane helices.
To model the ternary complex characteristic for allosteric interactions, NMS was placed in the orthosteric site as described previously (Vogel et al.,1997; Heitz et al., 1999) . Then diallylcaracurine V in the conformation illustrated in Fig. 1 , which is based on the 3D structure of caracurine V as determined by Zlotos (2000) , could easily be docked into the entrance of the ligand binding cavity (Fig. 8) . The molecular dynamics simulation performed subsequently indicated that the aromatic ring of M 2 -Tyr 177 is prone to make an upward movement toward the allosteric agent. Thereby, the aromatic ring of M 2 -Tyr 177 approaches the adjacent aromatic ring of the allosteric agent, leading to the formation of a -interaction (Fig. 9) . The movement of M 2 -Tyr 177 takes place at the expense of free volume in the region connecting the two binding sites; consequently, the corridor between the orthosteric site and the allosteric site is closed and NMS is trapped (Fig. 8) . In the NMS-liganded mutant M 2 -Tyr 177 3 Gln, the conformation of the allosteric site is not changed compared with the wild-type M 2 . In this mutant, docking of diallylcaracurine V is followed by a movement of Gln away from the allosteric agent [i.e., into the opposite direction compared with the movement of Tyr in the wild-type receptor (Fig. 10) ]. This is accompanied by a considerable loss of interaction energy (Fig. 11, top) .
We have also studied the M 2 -Thr 423 3 His mutant receptor. M 2 -Thr 423 is located near one of the ether oxygens of diallylcaracurine V. In the mutant, the interaction energy converts from an attractive to a repulsive term (Fig. 11, bottom) . Taken together, these results are in line with the experimental findings; i.e., the loss of binding affinity of diallylcaracurine V is greater in M 2 - , and Ala 13 ), the residues comprising these pockets lie in or near regions of the receptor that are significantly conserved across the muscarinic family. Furthermore, these residues are themselves highly conserved between M 2 and M 5 and throughout the family.
To assign a realistic low energy conformation for the highly flexible W84, a conformational analysis was performed. For this purpose molecular dynamics simulations in an aqueous environment were employed (Höltje and Folkers, 1996) . This procedure leads to a conformation of W84 that differs from the S-shape low energy conformer detected by Holzgrabe and Hopfinger (1996) in the course of a systematic analysis in Fig. 10 vacuo. The conformation resulting from the dynamical treatment of W84 was docked to the NMS-occupied receptor. W84 fills the ligand binding cavity and one phthalimido-group approaches M 2 -Tyr 177 and M 2 -Thr 423 (Fig. 12) ; the quaternary nitrogens are found in similar positions as described above for diallylcaracurine V. The M 2 -Tyr 177 3 Gln mutant leads to a comparable loss of interaction energy and a geometry comparable to that described for diallylcaracurine V. Mutating M 2 -Thr 423 to His causes nearly no difference in the interaction energy in this position but reduces the interaction energy between W84 and the conserved tryptophans by influencing their side-chain conformation (data not shown). Taken together, the results of the docking simulations carried out with the three-dimensional model correspond with the experimental findings from the binding assays in the wild-type M 2 and the mutant M 2 receptors.
Discussion
In this study, we have identified M 2 -Tyr 177 in o2 as a second essential epitope for the high-affinity binding of some structurally diverse muscarinic allosteric agents in M 2 receptors whose orthosteric site is occupied by the muscarinic antagonist N-methylscopolamine. This amino acid, together with the previously identified M 2 -Thr 423 at the beginning of TM7 (Buller et al., 2002) , account entirely for the M 2 /M 5 selectivity. For each of the three ligands investigated in the present study, the substitution of M 2 -Tyr 177 resulted in a more pronounced loss of affinity than substitution of M 2 - Table 2 ). Thus, M 2 -Tyr 177 seems to be more important for the binding affinity of these allosteric test compounds than the previously identified M 2 -Thr 423 . Yet, this is not a general phenomenon, because the allosteric affinity of the methyl analog of diallylcaracurine V has been shown to be affected much more by mutation at the M 2 -Thr 423 than by substitution of the entire o2 loop (Buller et al., 2002) .
Multiple studies have indicated that residues in the second outer loop or near the junction of the third outer loop and the top of TM7 are important in the binding of muscarinic allosteric ligands. The EDGE sequence (residues 172-175 in M 2 ) markedly affects the binding of gallamine (Leppik et al., 1994; Gnagey et al., 1999) . The asparagine residue at M 2 419 has been implicated in the subtype selectivities of gallamine and alcuronium (Gnagey et al., 1999; Krejči and Tuček, 2001 ). Elimination of a tryptophan residue that is conserved among all five muscarinic receptor subtypes (located at position 422 in M 2 ) reduces the affinity of gallamine and other allosteric ligands (Matsui et al., 1995) . More general studies using chimeric receptors have also suggested that these two regions of the receptor (i.e., o2 and o3) are critical to the binding or selectivity of many muscarinic allosteric ligands, although the relative importance of the regions varies from ligand to ligand (Ellis and Seidenberg, 2000) . Nevertheless, many of these compounds seem to interact competitively at a common allosteric site (Ellis and Seidenberg, 1992; 2000; Trä nkle and Mohr, 1997) , perhaps reflecting the close proximity of the residues involved, either near the middle of o2 or near the o3/TM7 junction. In keeping with the above studies, the agents investigated in the present study were sensitive to residues in these two regions: the recently described threonine near o3/TM7 and the tyrosine in o2 that is the main finding of the present study. It remains to be seen whether another group of compounds, which does not seem to interact competitively with gallamine and the others (Trä nkle and Mohr, 1997; Lazareno et al., 2000) , may bind to regions other than o2 and o3.
The present findings made with diallylcaracurine V reveal that the pair of amino acids, M 2 -Tyr 177 and M 2 -Thr 423 , is also involved in the M 2 /M 5 selectivity of the binding affinity for NMS-free receptors. The affinity of diallylcaracurine V for the NMS-free M 2 double mutant receptor does not reach the level of M 5 . Thus, the pair of amino acids does not completely account for the M 2 /M 5 selectivity in free receptors, and one or more additional epitopes seem to be involved.
Nevertheless, for NMS-occupied receptors, the present study is the first to identify epitopes that fully explain the M 2 /M 5 selectivity of structurally different allosteric agents. The finding is a good starting point to develop a three-dimensional model of the M 2 receptor and to check its validity. Docking NMS into the orthosteric site has the advantage that NMS stabilizes an inactive conformation of the receptor protein; in addition, the possibility is excluded that the allosteric agent may use elements of the orthosteric site. The two amino acids identified in the present study can serve as probes to check the model in that these amino acids should be involved in a meaningful fashion in the docking of the allosteric agents. In fact, the model provides a hypothesis of how the alkane-bisammonium-type agent W84 and the caracurine derivative, although structurally diverse, could interact with the same two epitopes. In principle, the amino acids identified here as essential epitopes for the high binding affinity of the allosteric agents in M 2 relative to M 5 receptors could either be important for the overall conformation of the allosteric site or they could be docking points. In the 3D model, the exchange of M 2 -Tyr 177 by the corresponding Gln of M 5 did not affect the conformation of the allosteric site. In contrast, a mutation from the acidic M 2 sequence EDGE, located near M 2 -Tyr 177 , into the corresponding sequence PLDE of M 5 would change the proposed ␤-IЈ-turn and hereby the loop conformation and the allosteric binding site (data not shown). Upon docking of diallylcaracurine V to the wild-type M 2 receptor, M 2 -Tyr 177 makes a movement in the sense of an induced fit, whereas in the mutant receptor M 2 -Tyr 177 3 Gln, the glutamine moves in the opposite direction (i.e., away from the allosteric agent). M 2 -Thr 423 is situated just between two tryptophans that are conserved in muscarinic receptors. The effect of the M 2 -Thr 423 3 His mutation seems to be a direct interaction in the case of diallylcaracurine V, whereas in the case of W84, it is more likely to be a steric influence on the relative orientation of the two tryptophans. Taken together, the model recognizes M 2 -Tyr 177 and M 2 -Thr 423 as essential sites of attachment. At the same time, the allosteric ligands also possess significant affinity for the M 5 receptor subtype. We have speculated previously that a core binding region common to all of the receptor subtypes is likely to exist and that allosteric ligands bind to the different subtypes with similar orientations (Ellis, 1997; Buller et al., 2002) . It remains to be seen whether the conserved residues that make up the lipophilic pockets, which we have identified in the model of the M 2 receptor, contribute to a core binding region of the allosteric site for the receptor family.
In summary, we have identified a second amino acid, M 2 -Tyr 177 in o2, which, together with M 2 -Thr 423 at the top of TM7, accounts entirely for the M 2 /M 5 selectivity of alkanebisammonium-type and caracurine V-type allosteric modulators at muscarinic acetylcholine receptors that are occupied by the antagonist N-methylscopolamine. In free receptors, the pair of epitopes clearly contributes to the binding affinity of the modulators for M 2 receptors, but it does not seem to fully account for the M 2 /M 5 selectivity. A three-dimensional model of the NMS-occupied M 2 muscarinic acetylcholine receptor has been developed that accommodates the experimentally observed phenomena and may provide insight into the topography and the molecular mechanisms of allostericorthosteric-interactions. 
